November 27, 2019

Bloomberg: MiMedx Indictments Could Mean the Worst Is Over

According to prosecutors, MiMedx reported revenue of $187.3 million in 2015. The alleged fraudulent activity accounted for just $9.5 million of that amount. One suspects that the earnings restatement, when it is finally completed, will mollify investors rather than alarm them. (via Bloomberg)

Get our latest Reports delivered to your inbox

© 2023 Prescience Point Capital Management. All rights reserved. Site by North Street.

Prescience Investment Group, LLC is a Registered Investment Advisor with the State of Louisiana and is not currently required to register in any other state. Prescience Investment Group, LLC may only conduct advisory business in those states in which it is registered as an investment adviser or qualifies for a corresponding exemption or exclusion from registration requirements.